Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70418 |
TLN-232
|
||
TLN-232, also known as CAP-232, is a synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells. | |||
T70417 |
XR 1853
|
||
XR 1853 is a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. |